Cargando…
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
PURPOSE: To compare the efficacy of intravitreal injection of bevacizumab alone or combined with intravitreal triamcinolone as the primary treatment for cases with diabetic macular edema (DME). METHODS: Ninety eyes were enrolled in one of the three study arms; where intravitreal triamcinolone aceton...
Autores principales: | Marey, Hatem M, Ellakwa, Amin F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151562/ https://www.ncbi.nlm.nih.gov/pubmed/21845026 http://dx.doi.org/10.2147/OPTH.S22103 |
Ejemplares similares
-
Comparison of the Short-Term Effects of Intravitreal Triamcinolone Acetonide and Bevacizumab Injection for Diabetic Macular Edema
por: Song, Ju Hwan, et al.
Publicado: (2011) -
Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection
por: Kim, Min Woo, et al.
Publicado: (2016) -
A Prospective, Randomized Comparison of Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab (Avastin) in Diffuse Diabetic Macular Edema
por: Shahin, Maha M., et al.
Publicado: (2010) -
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
por: Zakaria, Yousra Gamal, et al.
Publicado: (2022) -
Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)